Page last updated: 2024-10-18

dalteparin and Retinal Diseases

dalteparin has been researched along with Retinal Diseases in 3 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Retinal Diseases: Diseases involving the RETINA.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beato, J1
Fígueira, L1
Penas, S1
Santos-Silva, R1
Falcão, M1
Carneiro, Â1
Reis, FF1
Bick, RL1
Alfar, H1
Goedecke, C1
Aggermann, T1
Haas, P1
Binder, S1

Other Studies

3 other studies available for dalteparin and Retinal Diseases

ArticleYear
Presumed bilateral cilioretinal artery occlusion related to relapsing white dot syndrome.
    European journal of ophthalmology, 2016, Aug-04, Volume: 26, Issue:5

    Topics: Arterial Occlusive Diseases; Aspirin; Ciliary Arteries; Coloring Agents; Drug Therapy, Combination;

2016
Thrombophilic causes of retinal vascular thrombosis: etiology and treatment outcomes.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2002, Volume: 8, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Clinical Laboratory Techniques; Clopidogrel; Da

2002
Central retinal vein occlusion as a possible presenting manifestation of Sneddon syndrome.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2007, Volume: 27, Issue:3

    Topics: Dalteparin; Fibrinolytic Agents; Fundus Oculi; Humans; Livedo Reticularis; Male; Middle Aged; Pentox

2007